A novel immunological assay for hepcidin quantification in human serum.

BACKGROUND: Hepcidin is a 25-aminoacid cysteine-rich iron regulating peptide. Increased hepcidin concentrations lead to iron sequestration in macrophages, contributing to the pathogenesis of anaemia of chronic disease whereas decreased hepcidin is observed in iron deficiency and primary iron overloa...

Full description

Bibliographic Details
Main Authors: Vasiliki Koliaraki, Martha Marinou, Theodoros P Vassilakopoulos, Eustathios Vavourakis, Emmanuel Tsochatzis, Gerassimos A Pangalis, George Papatheodoridis, Alexandra Stamoulakatou, Dorine W Swinkels, George Papanikolaou, Avgi Mamalaki
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2640459?pdf=render
id doaj-0a484668243c496b921ee0309b75c366
record_format Article
spelling doaj-0a484668243c496b921ee0309b75c3662020-11-25T02:28:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-01-0142e458110.1371/journal.pone.0004581A novel immunological assay for hepcidin quantification in human serum.Vasiliki KoliarakiMartha MarinouTheodoros P VassilakopoulosEustathios VavourakisEmmanuel TsochatzisGerassimos A PangalisGeorge PapatheodoridisAlexandra StamoulakatouDorine W SwinkelsGeorge PapanikolaouAvgi MamalakiBACKGROUND: Hepcidin is a 25-aminoacid cysteine-rich iron regulating peptide. Increased hepcidin concentrations lead to iron sequestration in macrophages, contributing to the pathogenesis of anaemia of chronic disease whereas decreased hepcidin is observed in iron deficiency and primary iron overload diseases such as hereditary hemochromatosis. Hepcidin quantification in human blood or urine may provide further insights for the pathogenesis of disorders of iron homeostasis and might prove a valuable tool for clinicians for the differential diagnosis of anaemia. This study describes a specific and non-operator demanding immunoassay for hepcidin quantification in human sera. METHODS AND FINDINGS: An ELISA assay was developed for measuring hepcidin serum concentration using a recombinant hepcidin25-His peptide and a polyclonal antibody against this peptide, which was able to identify native hepcidin. The ELISA assay had a detection range of 10-1500 microg/L and a detection limit of 5.4 microg/L. The intra- and interassay coefficients of variance ranged from 8-15% and 5-16%, respectively. Mean linearity and recovery were 101% and 107%, respectively. Mean hepcidin levels were significantly lower in 7 patients with juvenile hemochromatosis (12.8 microg/L) and 10 patients with iron deficiency anemia (15.7 microg/L) and higher in 7 patients with Hodgkin lymphoma (116.7 microg/L) compared to 32 age-matched healthy controls (42.7 microg/L). CONCLUSIONS: We describe a new simple ELISA assay for measuring hepcidin in human serum with sufficient accuracy and reproducibility.http://europepmc.org/articles/PMC2640459?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Vasiliki Koliaraki
Martha Marinou
Theodoros P Vassilakopoulos
Eustathios Vavourakis
Emmanuel Tsochatzis
Gerassimos A Pangalis
George Papatheodoridis
Alexandra Stamoulakatou
Dorine W Swinkels
George Papanikolaou
Avgi Mamalaki
spellingShingle Vasiliki Koliaraki
Martha Marinou
Theodoros P Vassilakopoulos
Eustathios Vavourakis
Emmanuel Tsochatzis
Gerassimos A Pangalis
George Papatheodoridis
Alexandra Stamoulakatou
Dorine W Swinkels
George Papanikolaou
Avgi Mamalaki
A novel immunological assay for hepcidin quantification in human serum.
PLoS ONE
author_facet Vasiliki Koliaraki
Martha Marinou
Theodoros P Vassilakopoulos
Eustathios Vavourakis
Emmanuel Tsochatzis
Gerassimos A Pangalis
George Papatheodoridis
Alexandra Stamoulakatou
Dorine W Swinkels
George Papanikolaou
Avgi Mamalaki
author_sort Vasiliki Koliaraki
title A novel immunological assay for hepcidin quantification in human serum.
title_short A novel immunological assay for hepcidin quantification in human serum.
title_full A novel immunological assay for hepcidin quantification in human serum.
title_fullStr A novel immunological assay for hepcidin quantification in human serum.
title_full_unstemmed A novel immunological assay for hepcidin quantification in human serum.
title_sort novel immunological assay for hepcidin quantification in human serum.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2009-01-01
description BACKGROUND: Hepcidin is a 25-aminoacid cysteine-rich iron regulating peptide. Increased hepcidin concentrations lead to iron sequestration in macrophages, contributing to the pathogenesis of anaemia of chronic disease whereas decreased hepcidin is observed in iron deficiency and primary iron overload diseases such as hereditary hemochromatosis. Hepcidin quantification in human blood or urine may provide further insights for the pathogenesis of disorders of iron homeostasis and might prove a valuable tool for clinicians for the differential diagnosis of anaemia. This study describes a specific and non-operator demanding immunoassay for hepcidin quantification in human sera. METHODS AND FINDINGS: An ELISA assay was developed for measuring hepcidin serum concentration using a recombinant hepcidin25-His peptide and a polyclonal antibody against this peptide, which was able to identify native hepcidin. The ELISA assay had a detection range of 10-1500 microg/L and a detection limit of 5.4 microg/L. The intra- and interassay coefficients of variance ranged from 8-15% and 5-16%, respectively. Mean linearity and recovery were 101% and 107%, respectively. Mean hepcidin levels were significantly lower in 7 patients with juvenile hemochromatosis (12.8 microg/L) and 10 patients with iron deficiency anemia (15.7 microg/L) and higher in 7 patients with Hodgkin lymphoma (116.7 microg/L) compared to 32 age-matched healthy controls (42.7 microg/L). CONCLUSIONS: We describe a new simple ELISA assay for measuring hepcidin in human serum with sufficient accuracy and reproducibility.
url http://europepmc.org/articles/PMC2640459?pdf=render
work_keys_str_mv AT vasilikikoliaraki anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT marthamarinou anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT theodorospvassilakopoulos anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT eustathiosvavourakis anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT emmanueltsochatzis anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT gerassimosapangalis anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT georgepapatheodoridis anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT alexandrastamoulakatou anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT dorinewswinkels anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT georgepapanikolaou anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT avgimamalaki anovelimmunologicalassayforhepcidinquantificationinhumanserum
AT vasilikikoliaraki novelimmunologicalassayforhepcidinquantificationinhumanserum
AT marthamarinou novelimmunologicalassayforhepcidinquantificationinhumanserum
AT theodorospvassilakopoulos novelimmunologicalassayforhepcidinquantificationinhumanserum
AT eustathiosvavourakis novelimmunologicalassayforhepcidinquantificationinhumanserum
AT emmanueltsochatzis novelimmunologicalassayforhepcidinquantificationinhumanserum
AT gerassimosapangalis novelimmunologicalassayforhepcidinquantificationinhumanserum
AT georgepapatheodoridis novelimmunologicalassayforhepcidinquantificationinhumanserum
AT alexandrastamoulakatou novelimmunologicalassayforhepcidinquantificationinhumanserum
AT dorinewswinkels novelimmunologicalassayforhepcidinquantificationinhumanserum
AT georgepapanikolaou novelimmunologicalassayforhepcidinquantificationinhumanserum
AT avgimamalaki novelimmunologicalassayforhepcidinquantificationinhumanserum
_version_ 1724838000440901632